EDIT Editas Medicine, Inc.: institutional ownership and insider trading
229 funds reported holding $409M of Editas Medicine, Inc. in their latest 13F filings; in Q2 2026 funds net bought $222M, with 36 new positions and 25 funds selling out; over the last 12 months insiders bought $0 and sold $107K on the open market.
Famous investors holding EDIT
- Renaissance Technologies (Renaissance Technologies): $8.00M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $6.16M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.32M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.62M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.48M, 0.0% of the portfolio
Largest institutional holders of EDIT
- TCG Crossover Management, LLC — $36.0M
- BlackRock, Inc. (BLK) — $34.3M
- ADAR1 Capital Management, LLC — $28.8M
- Commodore Capital LP — $28.8M
- RA CAPITAL MANAGEMENT, L.P. — $28.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $19.9M
- Paradigm Biocapital Advisors LP — $18.1M
- VANGUARD GROUP INC — $16.8M
- Opaleye Management Inc. — $12.5M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $11.7M
Recent EDIT insider trades
- Sep 3, 2026: O'Neill Gilmore Neil sold 5,124 shares ($15.6K)
- Sep 3, 2026: Burkly Linda sold 709 shares ($2.16K)
- Sep 3, 2026: Parison Amy sold 453 shares ($1.38K)
- Aug 3, 2026: Parison Amy sold 678 shares ($1.75K)
5%+ owners
- Commodore Capital LP: 9.9% (Schedule 13G, filed Jun 2, 2026)
- TCG Crossover GP III, LLC: 9.9% (Schedule 13G, filed Jun 3, 2026)
- ADAR1 Capital Management, LLC: 5.8% (Schedule 13G, filed Aug 14, 2026)
- RA Capital Management, L.P.: 5.8% (Schedule 13G, filed Jun 3, 2026)